[1]
N. Gavryliuk, I. Hospodarskyy, O. Prokopchuk, O. Krekhovska-Lepiavko, B. Lokay, and M. Havrylyuk, “Comparative effectiveness of anti-fibrosis treatment in patients after HCV infection and in patients with non-alcoholic fatty liver disease (NAFLD)”, J Educ Health Sport, vol. 11, no. 2, pp. 222–229, Feb. 2021.